AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Insight Molecular Diagnostics Inc. Director's Dealing 2020

Apr 1, 2020

Director's Dealing

Opens in your device viewer

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2020-03-30

Reporting Person: ANDREWS RONALD ASBURY (Director, CEO and President)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-30	Common Stock, no par value	P	27216	$2.258	Acquired	44698	Direct
2020-03-31	Common Stock, no par value	P	18000	$2.372	Acquired	62698	Direct

F1: Amendment to correct March 31, 2020 share purchase price by replacing erroneous comma with a decimal point.